The present invention relates to at least one novel anti-dual integrinantibodies, including isolated nucleic acids that encode at least one anti-dual integrin antibody, dual integrin, vectors, host cells, transgenic animalsor plants, and methods of making and using thereof, including therapeuticcompositions, methods and devices.